Trial intelligence / Profile preview

Pre-surgical metformin for women with endometrial cancer

2014-000991-25Phase 3Completed

Sponsor
Manchester University NHS Foundation Trust
Start
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in endometrial cancer (EC) and endometrial hyperplasia (EH) comparing Metformin arm with Placebo arm (2 arms). Primary endpoint: Ki-67 proliferation index. Started Aug 2014; status: completed.

02

Drugs

metformin
03

Conditions

endometrial cancer (EC)endometrial hyperplasia (EH)

Beyond the preview

Go deeper on 2014-000991-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-000991-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call